

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001032"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001032" />

    <meta name="citation_title" content="Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice"/>
    <meta itemprop="name" content="Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice"/>

      <meta name="citation_author" content="Jae Hyang Lim"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Hirofumi Jono"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Tomoaki Koga"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Chang-Hoon Woo"/>
            <meta name="citation_author_institution" content="Cardiovascular Research Institute, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Hajime Ishinaga"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Patricia Bourne"/>
            <meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Haodong Xu"/>
            <meta name="citation_author_institution" content="Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Un-Hwan Ha"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Haidong Xu"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>
      <meta name="citation_author" content="Jian-Dong Li"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America"/>

    <meta name="citation_date" content="2007/10/10"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001032.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1032"/>
    <meta name="citation_issue" content="10"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Nontypeable Haemophilus influenzae: pathogenesis and prevention.; citation_author=AR Foxwell; citation_author=JM Kyd; citation_author=AW Cripps; citation_journal_title=Microbiol Mol Biol Rev; citation_volume=62; citation_number=1; citation_pages=294-308; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae.; citation_author=VK Rao; citation_author=GP Krasan; citation_author=DR Hendrixson; citation_author=S Dawid; citation_author=JW St Geme; citation_journal_title=FEMS Microbiol Rev; citation_volume=23; citation_number=2; citation_pages=99-129; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Chronic obstructive pulmonary disease.; citation_author=S Sethi; citation_author=TF Murphy; citation_journal_title=N Engl J Med; citation_volume=343; citation_number=3; citation_pages=1969-1970; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Haemophilus influenzae in chronic bronchitis.; citation_author=TF Murphy; citation_journal_title=Semin Respir Infect; citation_volume=15; citation_number=4; citation_pages=41-51; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.; citation_author=TF Murphy; citation_journal_title=Curr Opin Infect Dis; citation_volume=19; citation_number=5; citation_pages=225-230; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.; citation_author=T Watanabe; citation_author=H Jono; citation_author=J Han; citation_author=DJ Lim; citation_author=JD Li; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=101; citation_number=6; citation_pages=3563-3568; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Signaling to NF-kappaB.; citation_author=MS Hayden; citation_author=S Ghosh; citation_journal_title=Genes Dev; citation_volume=18; citation_number=7; citation_pages=2195-2224; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Missing pieces in the NF-kappaB puzzle.; citation_author=S Ghosh; citation_author=M Karin; citation_journal_title=Cell; citation_volume=109:; citation_number=8; citation_pages=S81-96; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.; citation_author=T Shuto; citation_author=H Xu; citation_author=B Wang; citation_author=J Han; citation_author=H Kai; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=98; citation_number=9; citation_pages=8774-8779; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2.; citation_author=A Imasato; citation_author=C Desbois-Mouthon; citation_author=J Han; citation_author=H Kai; citation_author=AC Cato; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=10; citation_pages=47444-47450; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.; citation_author=RJ Ulevitch; citation_author=PS Tobias; citation_journal_title=Annu Rev Immunol; citation_volume=13; citation_number=11; citation_pages=437-457; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.; citation_author=EA Kurt-Jones; citation_author=M Chan; citation_author=S Zhou; citation_author=J Wang; citation_author=G Reed; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=101; citation_number=12; citation_pages=1315-1320; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Identification of the familial cylindromatosis tumour-suppressor gene.; citation_author=GR Bignell; citation_author=W Warren; citation_author=S Seal; citation_author=M Takahashi; citation_author=E Rapley; citation_journal_title=Nat Genet; citation_volume=25; citation_number=13; citation_pages=160-165; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.; citation_author=N Leonard; citation_author=R Chaggar; citation_author=C Jones; citation_author=M Takahashi; citation_author=A Nikitopoulou; citation_journal_title=J Clin Pathol; citation_volume=54; citation_number=14; citation_pages=689-692; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.; citation_author=P Poblete Gutierrez; citation_author=T Eggermann; citation_author=D Holler; citation_author=FK Jugert; citation_author=T Beermann; citation_journal_title=J Invest Dermatol; citation_volume=119; citation_number=15; citation_pages=527-531; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.; citation_author=E Trompouki; citation_author=E Hatzivassiliou; citation_author=T Tsichritzis; citation_author=H Farmer; citation_author=A Ashworth; citation_journal_title=Nature; citation_volume=424; citation_number=16; citation_pages=793-796; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.; citation_author=TR Brummelkamp; citation_author=SM Nijman; citation_author=AM Dirac; citation_author=R Bernards; citation_journal_title=Nature; citation_volume=424; citation_number=17; citation_pages=797-801; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.; citation_author=A Kovalenko; citation_author=C Chable-Bessia; citation_author=G Cantarella; citation_author=A Israel; citation_author=D Wallach; citation_journal_title=Nature; citation_volume=424; citation_number=18; citation_pages=801-805; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Negative regulation of JNK signaling by the tumor suppressor CYLD.; citation_author=W Reiley; citation_author=M Zhang; citation_author=SC Sun; citation_journal_title=J Biol Chem; citation_volume=279; citation_number=19; citation_pages=55161-55167; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.; citation_author=H Yoshida; citation_author=H Jono; citation_author=H Kai; citation_author=JD Li; citation_journal_title=J Biol Chem; citation_volume=280; citation_number=20; citation_pages=41111-41121; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.; citation_author=J Zhang; citation_author=B Stirling; citation_author=ST Temmerman; citation_author=CA Ma; citation_author=IJ Fuss; citation_journal_title=J Clin Invest; citation_volume=116; citation_number=21; citation_pages=3042-3049; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.; citation_author=WW Reiley; citation_author=W Jin; citation_author=AJ Lee; citation_author=A Wright; citation_author=X Wu; citation_journal_title=J Exp Med; citation_volume=204; citation_number=22; citation_pages=1475-1485; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.; citation_author=H Jono; citation_author=JH Lim; citation_author=LF Chen; citation_author=H Xu; citation_author=E Trompouki; citation_journal_title=J Biol Chem; citation_volume=279; citation_number=23; citation_pages=36171-36174; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.; citation_author=O Takeuchi; citation_author=K Hoshino; citation_author=S Akira; citation_journal_title=J Immunol; citation_volume=165; citation_number=24; citation_pages=5392-5396; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK.; citation_author=SM Kweon; citation_author=B Wang; citation_author=D Rixter; citation_author=JH Lim; citation_author=T Koga; citation_journal_title=Biochem Biophys Res Commun; citation_volume=351; citation_number=25; citation_pages=368-375; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells.; citation_author=A Sakai; citation_author=J Han; citation_author=AC Cato; citation_author=S Akira; citation_author=JD Li; citation_journal_title=BMC Mol Biol,; citation_volume=5; citation_number=26; citation_pages=2; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells.; citation_author=S Kim; citation_author=AJ Schein; citation_author=JA Nadel; citation_journal_title=Am J Physiol Lung Cell Mol Physiol; citation_volume=289; citation_number=27; citation_pages=L1049-1060; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.; citation_author=A Dunne; citation_author=LA O'Neill; citation_journal_title=Sci STKE; citation_volume=2003; citation_number=28; citation_pages=re3; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Toll-like receptor signalling.; citation_author=S Akira; citation_author=K Takeda; citation_journal_title=Nat Rev Immunol; citation_volume=4; citation_number=29; citation_pages=499-511; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Inferences, questions and possibilities in Toll-like receptor signalling.; citation_author=B Beutler; citation_journal_title=Nature; citation_volume=430; citation_number=30; citation_pages=257-263; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Negative regulation of toll-like receptor-mediated immune responses.; citation_author=FY Liew; citation_author=D Xu; citation_author=EK Brint; citation_author=LA O'Neill; citation_journal_title=Nat Rev Immunol; citation_volume=5; citation_number=31; citation_pages=446-458; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.; citation_author=L Deng; citation_author=C Wang; citation_author=E Spencer; citation_author=L Yang; citation_author=A Braun; citation_author=J You; citation_journal_title=Cell; citation_volume=103; citation_number=32; citation_pages=351-361; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.; citation_author=J Inoue; citation_author=T Ishida; citation_author=N Tsukamoto; citation_author=N Kobayashi; citation_author=A Naito; citation_journal_title=Exp Cell Res; citation_volume=254; citation_number=33; citation_pages=14-24; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Themes and variations on ubiquitylation.; citation_author=AM Weissman; citation_journal_title=Nat Rev Mol Cell Biol; citation_volume=2; citation_number=34; citation_pages=169-178; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Regulatory functions of ubiquitination in the immune system.; citation_author=Y Ben-Neriah; citation_journal_title=Nat Immunol; citation_volume=3; citation_number=35; citation_pages=20-26; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.; citation_author=H Habelhah; citation_author=S Takahashi; citation_author=SG Cho; citation_author=T Kadoya; citation_author=T Watanabe; citation_journal_title=EMBO J; citation_volume=23; citation_number=36; citation_pages=322-332; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.; citation_author=T Fukushima; citation_author=S Matsuzawa; citation_author=CL Kress; citation_author=JM Bruey; citation_author=M Krajewska; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=104; citation_number=37; citation_pages=6371-6376; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Ubiquitin signalling in the NF-kappaB pathway.; citation_author=ZJ Chen; citation_journal_title=Nat Cell Biol; citation_volume=7; citation_number=38; citation_pages=758-765; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Regulation of T cell development by the deubiquitinating enzyme CYLD.; citation_author=WW Reiley; citation_author=M Zhang; citation_author=W Jin; citation_author=M Losiewicz; citation_author=KB Donohue; citation_journal_title=Nat Immunol; citation_volume=7; citation_number=39; citation_pages=411-417; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.; citation_author=R Massoumi; citation_author=K Chmielarska; citation_author=K Hennecke; citation_author=A Pfeifer; citation_author=R Fassler; citation_journal_title=Cell; citation_volume=125; citation_number=40; citation_pages=665-677; citation_date=2006; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice"/>
    <meta name="twitter:description" content="Non-typeable Haemophilus influenza (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor kappaB (NF-&kappa;B)-dependent production of inflammatory mediators. The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-&kappa;B in vitro. However, little is known about the role of CYLD in bacteria-induced inflammation in vivo. Here, we provided direct evidence for the negative role of CYLD in NTHi-induced inflammation of the mice in vivo. Our data demonstrated that CYLD is induced by NTHi in the middle ear and lung of mice. NTHi-induced CYLD, in turn, negatively regulates NTHi-induced NF-&kappa;B activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation. Our data thus indicate that CYLD acts as a negative regulator for NF-&kappa;B-dependent inflammation in vivo, hence protecting the host against detrimental inflammatory response to NTHi infection."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001032.g006"/>

  <meta property="og:title" content="Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=6843'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=7962'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=3094&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001032">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001032" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001032&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable <i>Haemophilus influenza</i>-Induced Inflammation in the Middle Ear and Lung of Mice
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jae Hyang Lim, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Hirofumi Jono, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Tomoaki Koga, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chang-Hoon Woo, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Cardiovascular Research Institute, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Hajime Ishinaga, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Patricia Bourne, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Haodong Xu, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Un-Hwan Ha, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Haidong Xu, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jian-Dong Li
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:Jian-Dong_Li@urmc.rochester.edu">Jian-Dong_Li@urmc.rochester.edu</a></p>

                <p>Affiliation:
                  Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: October 10, 2007</li>
    <li>DOI: 10.1371/journal.pone.0001032</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001032-g001" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001032-g002" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001032-g003" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001032-g004" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001032-g005" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001032-g006" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001032">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001032" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>Non-typeable <em>Haemophilus influenza</em> (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor kappaB (NF-κB)-dependent production of inflammatory mediators. The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-κB <em>in vitro</em>. However, little is known about the role of CYLD in bacteria-induced inflammation <em>in vivo</em>. Here, we provided direct evidence for the negative role of CYLD in NTHi-induced inflammation of the mice <em>in vivo</em>. Our data demonstrated that CYLD is induced by NTHi in the middle ear and lung of mice. NTHi-induced CYLD, in turn, negatively regulates NTHi-induced NF-κB activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation. Our data thus indicate that CYLD acts as a negative regulator for NF-κB-dependent inflammation <em>in vivo</em>, hence protecting the host against detrimental inflammatory response to NTHi infection.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Lim JH, Jono H, Koga T, Woo C-H, Ishinaga H, et al.  (2007) Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable <em>Haemophilus influenza</em>-Induced Inflammation in the Middle Ear and Lung of Mice. PLoS ONE 2(10):
          e1032.
            doi:10.1371/journal.pone.0001032</p><p><strong>Academic Editor: </strong>Jacques Zimmer, Centre de Recherche Public-Santé, Luxembourg</p><p><strong>Received:</strong> September 7, 2007; <strong>Accepted:</strong> September 18, 2007; <strong>Published:</strong> October 10, 2007</p><p><strong>Copyright:</strong> © 2007 Lim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was supported by grants from National Institute of Health DC004562 and DC005843 to J.D. Li.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Nontypeable <em>Haemophilus influenzae</em> (NTHi), a gram-negative bacterium, is an important human pathogen in both adults and children <a href="#pone.0001032-Foxwell1">[1]</a>. In adults, it exacerbates chronic obstructive pulmonary diseases, and in children, it causes otitis media, the most common childhood infection and the leading cause of conductive hearing loss <a href="#pone.0001032-Rao1">[2]</a>–<a href="#pone.0001032-Murphy1">[4]</a>. Despite the need for prophylactic measures, development of a vaccine for preventing NTHi infections has been difficult and still remains a great challenge. Moreover, inappropriate antibiotic treatment contributes to the worldwide emergence of antibiotic-resistant strains of NTHi. Therefore, there is an urgent need for developing alternative therapeutic strategies for the treatment of NTHi infections based on understanding the molecular pathogenesis of NTHi infections. Like most other bacterial infections, NTHi infection is characterized by inflammation, which is mainly mediated by nuclear factor kappaB (NF-κB)-dependent production of pro-inflammatory mediators <a href="#pone.0001032-Murphy2">[5]</a>–<a href="#pone.0001032-Ghosh1">[8]</a>. We have previously shown that NTHi induces Toll-like receptor (TLR) 2-dependent activation of NF-κB via an IKKβ-IκBα- and p38 mitogen-activated protein kinase (MAPK)-dependent signaling pathway <a href="#pone.0001032-Watanabe1">[6]</a>, <a href="#pone.0001032-Shuto1">[9]</a>, <a href="#pone.0001032-Imasato1">[10]</a>. However, the key signaling adaptors that link TLR2 with IKK and MAPK in mediating NTHi-induced inflammation remain unknown.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Although the inflammatory response triggered by bacteria is essential for eradicating bacterial pathogen, excessive inflammatory response is clearly detrimental to the host, due to severe tissue damage <a href="#pone.0001032-Ulevitch1">[11]</a>, <a href="#pone.0001032-KurtJones1">[12]</a>. To avoid overactive and detrimental inflammatory response in infectious disease, the bacteria-induced inflammatory response must be tightly regulated. During evolution, the host has developed a variety of strategies to prevent detrimental inflammatory response during bacterial infections. Among all strategies, bacteria-induced negative feedback regulation is thought to play a critical role in preventing overactive inflammatory response by tightly regulating the activity of the key receptor-dependent signaling adaptors specifically activated by bacterial pathogens. In the pathogenesis of chronic obstructive pulmonary diseases and otitis media, to avoid detrimental inflammatory responses in NTHi infection, TLR2 signaling must be tightly regulated. However, despite the importance of tight regulation in preventing overactive inflammatory response, the molecular mechanisms underlying the negative feedback regulation of inflammation in the pathogenesis of NTHi infection remain unknown.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>CYLD was originally identified as a tumor suppressor, loss of which causes a benign human syndrome called cylindromatosis <a href="#pone.0001032-Bignell1">[13]</a>–<a href="#pone.0001032-PobleteGutierrez1">[15]</a>. <em>In vitro</em> studies have indicated that CYLD is a member of the deubiquitinating enzyme family that specifically digests polyubiquitin chains. Transfection studies showed that CYLD deubiquitinates TRAF2 and TRAF6 and acts as a negative regulator for activation of NF-κB by tumor necrosis factor receptor (TNFR) and TLR <a href="#pone.0001032-Trompouki1">[16]</a>–<a href="#pone.0001032-Kovalenko1">[18]</a>. Recently, we, together with others, showed that CYLD also negatively regulates activation of MAPKs, including p38 MAPK <a href="#pone.0001032-Reiley1">[19]</a>–<a href="#pone.0001032-Reiley2">[22]</a>. Moreover, the expression of CYLD is itself under the control of NF-κB <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a>, suggesting that CYLD is involved in a negative feedback regulation of NF-κB activation and NF-κB-dependent gene expression. Given the important role that NF-κB plays in host immune and inflammatory response in bacteria infection, it is logical to hypothesize that CYLD may act as a negative regulator for immune and inflammatory response against invading bacteria such as NTHi <em>in vivo</em>. However, despite recent studies demonstrating the role of CYLD in regulating T cell receptor signaling and tumor cell proliferation <em>in vivo</em>, the biological role of CYLD especially its negative role in inflammation <em>in vivo</em> still remains unknown.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>In the present study, by using NTHi-induced otitis media and pneumonia model in wild type (WT) and <em>Cyld</em>-deficient mice, we provide <em>in vivo</em> evidence that NTHi induces pro-inflammatory response through TLR2-dependent MyD88-TRAF6/7-NF-κB signaling pathway, and CYLD negatively regulates NF-κB-dependent inflammatory response by NTHi via deubiquitination of TRAF6 and TRAF7. These studies may lead to development of novel therapeutic strategies for controlling overactive inflammatory response in respiratory bacterial infections.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Mice</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p><em>Cyld<sup>−/−</sup></em> mice were generated by homologous recombination as previously reported <a href="#pone.0001032-Zhang1">[21]</a>. A <em>Cyld</em>-gene targeting construct was designed to delete exons 2 and 3 and replace them with a lacZ reporter and a neomycin resistance gene. The targeting vector was linearized and electroporated into 129S ES cells. Clones resistant to G417 were selected and screened for homologous recombinants by Southern blot analysis. Two targeted ES cell clones were microinjected into C57BL/6 blastocysts, and the resulting chimeras were mated to C57BL/6 females to generate mice heterozygous for the <em>Cyld</em> mutation. Homozygous knockout animals were obtained by mating of heterozygous males and females. Genotyping was performed by PCR on tail-derived genomic DNA, and absence of RNA transcript and protein expression was confirmed by RT-PCR and Western blot analysis. <em>Tlr2<sup>−/−</sup></em> and <em>MyD88<sup>+/−</sup></em> were described previously <a href="#pone.0001032-Takeuchi1">[24]</a>.</p>


<h4>Animal experiments</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>For NTHi-induced otitis media model in WT and <em>Cyld<sup>−/−</sup></em> mice, anaesthetized mice were transtympanically inoculated with 1×10<sup>7</sup> CFU of NTHi under the surgical microscope, and saline was inoculated as control. The inoculated mice were then sacrificed by intraperitoneal inoculation of 100 mg/kg sodium pentobarbital at 3, 6, 9, 24, 72, and 168 hours after inoculation of NTHi. Eardrum was inspected under the otoscope and findings were recorded. To assess the mRNA expression of inflammatory mediators, total RNA was extracted from the bulla of NTHi and saline-inoculated ear at the time points indicated above and real-time quantitative PCR (Q-PCR) was performed as described previously <a href="#pone.0001032-Yoshida1">[20]</a>. For histological analysis, dissected temporal bones were fixed with 10% buffered formaldehyde overnight with rocking, decalcified with CalEX, embedded in paraffin, and sectioned at 5-µM thickness. Sections were then stained with hematoxylin and eosin (H&amp;E) to visualize inflammatory response and pathological changes in the middle ear. H&amp;E-stained middle ear sections were then evaluated by light microscopy using Axiovert 40 CFL (Carl Zeiss), and images were recorded with an AxioCam MRC (Carl Zeiss). NTHi culture positivity was confirmed by bacterial culture of middle ear effusion from NTHi-inoculated ears.</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>For NTHi-induced pneumonia model in WT and <em>Cyld<sup>−/−</sup>, Tlr2<sup>−/−</sup>,</em> and <em>MyD88<sup>+/−</sup></em> mice, anaesthetized mice were intratracheally inoculated with 5×10<sup>7</sup> CFU of NTHi, and saline was inoculated as control. The inoculated mice were then sacrificed by intraperitoneal inoculation of 100 mg/kg sodium pentobarbital at the time points indicated above. For histological analysis, dissected lung was inflated and fixed with 10% buffered formaldehyde, embedded in paraffin, and sectioned at 5-µM thickness. Sections were then stained and inspected as described above. For polymorphonuclear neutrophil (PMN) analysis, bronchoalveolar lavage (BAL) was performed by cannulating the trachea with sterilized PBS. Cells from BAL fluid were stained with Hemacolor (EM Science) after cytocentrifugation (Thermo Electronic Co.). To assess the mRNA expression of inflammatory mediators, total RNA was extracted from the lung of NTHi and saline-inoculated lung at the time points indicated above and Q-PCR was performed as described previously <a href="#pone.0001032-Yoshida1">[20]</a>. All animal experiments were approved by the Institutional Animal Care and Use Committee at University of Rochester.</p>


<h4>Bacteria strain and culture</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Clinical isolate of NTHi wild-type strain 12 was used in <em>in vitro</em> cell culture experiments and <em>in vivo</em> animal experiments <a href="#pone.0001032-Shuto1">[9]</a>. Bacteria was grown on chocolate agar at 37°C in an atmosphere of 5% CO<sub>2</sub> for overnight and inoculated in brain heart infusion broth supplemented with 3.5 µg of NAD per ml (BHI). After overnight incubation, bacteria were subcultured into 5 ml of fresh BHI and the log phase NTHi that was monitored by measurement of optical density (OD) value was washed and suspended in phosphate-buffered saline for <em>in vitro</em> cell experiments and in isotonic saline for <em>in vivo</em> animal experiments. For <em>in vitro</em> experiments, the epithelial cells were treated with NTHi at a multiplicity of infection (MOI) of 1:25 for various times as indicated. For <em>in vivo</em> animal experiments, NTHi was inoculated into the middle ear for otitis media model and the lung for pneumonia at a concentration of 1×10<sup>7</sup> CFU/ear and 5×10<sup>7</sup> CFU/lung, respectively.</p>


<h4>Cell culture</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>Human middle ear epithelial cell line HMEEC-1, a commonly used middle ear cell line, was derived by human papilloma virus immortalization of primary human middle ear epithelial cells, and was maintained in a 1:1 mixutre of Bronchial Epithelial Basal Medium (BEBM) and Dulbecco's modified Eagle's medium (DMEM) as described <a href="#pone.0001032-Watanabe1">[6]</a>, <a href="#pone.0001032-Shuto1">[9]</a>, <a href="#pone.0001032-Kweon1">[25]</a>. Airway epithelial cell line A549 was maintained as described <a href="#pone.0001032-Shuto1">[9]</a>, <a href="#pone.0001032-Sakai1">[26]</a>. Primary normal human bronchial epithelial cell (NHBE) were purchased from Cambrex and were maintained as described previously in Bronchial Epithelial cell Growth Medium (BEGM) <a href="#pone.0001032-Watanabe1">[6]</a>, <a href="#pone.0001032-Jono1">[23]</a>, <a href="#pone.0001032-Kweon1">[25]</a>. For air-liquid interface culture, NHBE cells were cultured as described previously <a href="#pone.0001032-Kim1">[27]</a>. In brief, NHBE cells were seeded at 2×10<sup>4</sup> cells/cm<sup>2</sup> onto 24-mm-diameter, 0.4 µm pore size, semi-permeable membrane inserts (Corning) in BEBM. The cultures were grown submerged for the first 7 days and then, the air-liquid interface was created by removing media from the apical compartment of the cultures. The culture media were changed every other day until the air-liquid interface was created and were changed daily by replacing fresh media only to the basal compartment during the air-liquid interface culture. NHBE cells were grown in air-liquid interface for 2–3 weeks before being used for the proposed experiments. All cells were cultured in a humidified atmosphere of 5% CO<sub>2</sub> and 95% air at 37°C.</p>


<h4>Transfection and Small Interfering RNA (siRNA)</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>The plasmids TLR2, MyD88, TRAF6, and TRAF7 DN, WT CYLD, and NF-κB-luciferase reporter were described previously <a href="#pone.0001032-Watanabe1">[6]</a>, <a href="#pone.0001032-Shuto1">[9]</a>, <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a>, <a href="#pone.0001032-Kweon1">[25]</a>. Cells were cultured on 24-well plates. After 24 hours, cells were co-transfected with or without NF-κB-luciferase reporter plasmid and various expression plasmids as indicated in the figure legends. Empty vector was used as a control and was added where necessary to ensure a constant amount of input DNA. All transient transfections were carried out in triplicate using a TransIT-LT1 reagent (Mirus Co.) following the manufacturer's instructions. At 40 hours after the start of transfection, cells were inoculated with NTHi for 5 hours before cell lysis for luciferase assay or mRNA analysis as described previously. RNA-mediated interference for down-regulating CYLD expression was done using siRNA-CYLD as described previously <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a>.</p>


<h4>Western blot (WB) analysis and immunoprecipitation (IP)</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>Antibodies against TRAF6, HA and Ubiquitin were purchased from Santa Cruz Biotechnology, and CYLD was from IMGENEX.</p>
<a id="article1.body1.sec2.sec6.p2" name="article1.body1.sec2.sec6.p2"></a><p>Western blots were performed as described <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a> and following the manufacturer's instruction. Briefly, Western blots were performed using whole cell extracts, separated on 8–10% SDS-PAGE gels, and transferred to poly-vinylidine difluoride membranes. The membrane was blocked with 5% nonfat milk, incubated in a 1:2,000 dilution of a primary antibody, and incubated with 1:2,000 dilution of the corresponding secondary antibody. The membrane was reacted with chemiluminescence reagent ECL to visualize to blots. For immunoprecipitation, cell lysates were immunoprecipitated with 1 µg of the appropriate antibodies for overnight at 4°C and then conjugated to protein A/G-agarose beads for 2 hours at 4°C.</p>


<h4>Statistical analysis</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>Data were analyzed using Student's t-test. A value of <em>p&lt;0.05</em> was considered significant.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4><em>Cyld<sup>−/−</sup></em> mice are hyperresponsive to NTHi-induced inflammation in the ear and lung of the mice</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>To determine the biological role of CYLD in regulating inflammation <em>in vivo</em>, <em>Cyld</em>-deficient mice were generated by using standard targeting technique as described previously <a href="#pone.0001032-Zhang1">[21]</a>. Briefly, <em>Cyld<sup>−/−</sup></em> mice were generated by replacing exons 2 and 3 of <em>Cyld</em> gene with a neomycin resistance-lacZ cassette. Homozygous mutant was ascertained by PCR genotyping from tail tissue of mutant mice. RT-PCR analysis confirmed the absence of <em>Cyld</em> transcripts in <em>Cyld<sup>−/−</sup></em> mice, and immunoblot analysis of mouse embryonic fibroblast (MEF) using an antibody against CYLD showed <em>Cyld</em> deficiency. <em>Cyld</em>-deficient mice exhibit no overt abnormalities and have a normal lifespan.</p>
<a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>We next investigated the negative role of CYLD in inflammatory response against NTHi infection in the middle ear and lung of <em>Cyld<sup>−/−</sup></em> mice. Age- and sex-matched WT and <em>Cyld<sup>−/−</sup></em> mice were inoculated with NTHi and inflammatory response in the middle ear and lung of infected mice was monitored up to 7 days. Histological examination of the middle ear revealed enhanced inflammatory responses including enhanced leukocyte infiltration in <em>Cyld<sup>−/−</sup></em> mice compared with WT mice (<a href="#pone-0001032-g001"><strong>Fig. 1A</strong></a>). Consistent with this result, histological evaluation of the lung of NTHi-inoculated mice showed enhanced leukocyte infiltration in peribroncheal and interstitial area in <em>Cyld<sup>−/−</sup></em> mice compared with WT mice (<a href="#pone-0001032-g001"><strong>Fig. 1B</strong></a>).</p>
<div class="figure" id="pone-0001032-g001"><div class="img"><a name="pone-0001032-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span><em> Cyld<sup>−/−</sup></em> mice are hyperresponsive to NTHi-induced inflammation in the ear and lung of the mice.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>A, NTHi was trans-tympanically inoculated into the middle ears of WT and <em>Cyld<sup>−/−</sup></em> mice and bullaes were dissected from WT and <em>Cyld<sup>−/−</sup></em> mice inoculated with NTHi and saline for the control for histological analysis (H&amp;E stain, 200X). B, NTHi was intratracheally inoculated into the lungs of WT and <em>Cyld<sup>−/−</sup></em> mice and lung tissues were dissected from WT and <em>Cyld<sup>−/−</sup></em> mice inoculated with NTHi and saline for the control for histological analysis (H&amp;E stain, 200×). C &amp; D, NTHi was trans-tympanically (C) or intratracheally (D) inoculated into the middle ear (C) or lung (D), respectively, of WT and <em>Cyld<sup>−/−</sup></em> mice and mRNA expression of the inflammatory mediators, IL-1β and MIP-2, was measured by Q-PCR analysis *<em>p&lt;0.005</em> compared with control inoculation in WT mice, **<em>p&lt;0.05</em> compared with NTHi inoculation in WT mice. Values are means ± S.D. (n = 3). <em>CON</em>, control.</p>
<span>doi:10.1371/journal.pone.0001032.g001</span></div><a id="article1.body1.sec3.sec1.p3" name="article1.body1.sec3.sec1.p3"></a><p>NTHi-induced inflammatory response and leukocyte infiltration are mediated by pro-inflammatory mediators, including IL-1β and MIP-2 <a href="#pone.0001032-Murphy2">[5]</a>, <a href="#pone.0001032-Watanabe1">[6]</a>. Thus we measured expression of IL-1β and MIP-2 at mRNA levels in the middle ear and lung from both WT and <em>Cyld<sup>−/−</sup></em> mice 9 hours after NTHi inoculation. Compared with WT mice, <em>Cyld<sup>−/−</sup></em> mice showed higher levels of IL-1β and MIP-2 mRNA expression in the middle ear (<a href="#pone-0001032-g001"><strong>Fig. 1C</strong></a>) and in the lung (<a href="#pone-0001032-g001"><strong>Fig. 1D</strong></a>). In addition, we also found significant increases in the levels of TNF-α mRNA expression in <em>Cyld<sup>−/−</sup></em> mice (data not shown). These results demonstrate that CYLD plays an important role in negatively regulating NTHi-induced inflammatory response <em>in vivo</em>.</p>


<h4>NTHi-induced CYLD is responsible for down-regulation of inflammatory response</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>It is well known that a variety of genes involved in inflammatory response undergo changes in expression pattern in response to bacterial infection <a href="#pone.0001032-Dunne1">[28]</a>–<a href="#pone.0001032-Beutler1">[30]</a>. We recently found that the endogenous expression level of CYLD is relatively low in middle ear and lung under physiological condition <a href="#pone.0001032-Bignell1">[13]</a>, but highly inducible by bacterial pathogens <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a>, we hypothesized that CYLD is induced by NTHi and increased CYLD expression will in turn lead to inhibition of NTHi-induced inflammatory response, thereby preventing overactive inflammatory response that is detrimental to the host. We tested our hypothesis by first evaluating the effect of NTHi on CYLD expression. As shown in <a href="#pone-0001032-g002"><strong>Fig. 2A</strong></a>, NTHi induced CYLD expression at the mRNA level in middle ear HMEEC-1 cells. The induction of CYLD by NTHi was also confirmed at the protein level by performing Western blot analysis (<a href="#pone-0001032-g002"><strong>Fig. 2B</strong></a>). Similar result was also observed in human airway A549 cells and the primary human airway epithelial cells cultured under both regular liquid culture and physiological air-liquid interface condition (Data not shown). Moreover, up-regulation of CYLD by NTHi was also observed in the middle ear of NTHi-inoculated WT mice (<a href="#pone-0001032-g002"><strong>Fig. 2C</strong></a>). Marked induction of CYLD by NTHi was observed at 6–9 hours, and an even greater induction of CYLD was still observed at 3–7 days. Consistent with these findings, marked induction of CYLD by NTHi was observed in the lungs of NTHi-inoculated WT mice along with down-regulation of pro-inflammatory mediators, IL-1β and MIP-2 (<a href="#pone-0001032-g002"><strong>Fig. 2D &amp; E</strong></a>). It is interesting to note that the peak of CYLD induction was clearly preceded by the peak of the induction of IL-1β and MIP-2, thereby suggesting that NTHi-induced CYLD is responsible for down-regulation of inflammatory response.</p>
<div class="figure" id="pone-0001032-g002"><div class="img"><a name="pone-0001032-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>NTHi-induced CYLD is responsible for down-regulation of inflammatory response.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>A &amp; B, NTHi induced CYLD expression at both mRNA (A) and protein levels (B) in HMEEC-1 cells. C, NTHi induced CYLD expression at the mRNA level in the middle ear of WT mice. D &amp; E, NTHi induced expression of CYLD and IL-1β (D) or MIP-2 (E) at the mRNA level in the lung of WT mice. *<em>p&lt;0.05</em> compared with CON. Values are means ± S.D. (n = 3). <em>CON</em>, control.</p>
<span>doi:10.1371/journal.pone.0001032.g002</span></div>

<h4>NTHi induces inflammatory response through TLR2-MyD88-TRAF6/7-NF-κB signaling pathway</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>We next sought to identify the molecular target of CYLD in negatively regulating NTHi-induced inflammation. We first examined if TLR2-MyD88 and TRAFs, a family of adaptor proteins, are critically involved in mediating NTHi-induced inflammation. As shown in <a href="#pone-0001032-g003"><strong>Fig. 3A</strong></a>, overexpressing dominant-negative mutants of TLR2, MyD88 or TRAF6 or TRAF7, a newly identified member of TRAF family, inhibited NF-κB activation by NTHi in human middle ear HMEEC-1 cells. Similar results were also observed in human airway epithelial A549 cells and human primary bronchial epithelial NHBE cells (Data not shown). Moreover, overexpressing dominant-negative mutants of MyD88, TRAF6 or TRAF7 also inhibited NTHi-induced expression of IL-1β and IL-8 in HMEEC-1 cells (<a href="#pone-0001032-g003"><strong>Fig. 3B</strong></a>). Consistent with these <em>in vitro</em> findings, <em>Tlr2<sup>−/−</sup></em> mice showed significant reduction in both IL-1β and MIP-2 expression, when mice were intratracheally inoculated with NTHi (<a href="#pone-0001032-g003"><strong>Fig. 3C</strong></a>). Similar result was observed in <em>MyD88<sup>+/−</sup></em> mice (<a href="#pone-0001032-g003"><strong>Fig. 3D</strong></a>). Moreover, histological analysis of lungs of NTHi-inoculated mice revealed markedly reduced inflammatory response in <em>Tlr2<sup>−/−</sup></em> mice compared with WT mice (<a href="#pone-0001032-g003"><strong>Fig. 3E</strong></a>). Thus, it is evident that TLR2-dependent MyD88-TRAF6/7 signaling pathway plays a critical role in mediating NTHi-induced NF-κB-dependent inflammatory response <em>in vitro</em> and <em>in vivo</em>.</p>
<div class="figure" id="pone-0001032-g003"><div class="img"><a name="pone-0001032-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>NTHi induces inflammatory response through TLR2-MyD88-TRAF6/7-NF-κB signaling pathway.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>A &amp; B, Overexpressing dominant-negative (DN) mutants of TLR2, MyD88 and TRAF6/7 inhibited NTHi-induced activation of NF-κB (A) and up-regulation of IL-1β and IL-8 (B) in HMEEC-1 cells. *<em>p&lt;0.001</em>, compared with Mock. Values are means ± S.D. (n = 3). C, NTHi-induced expressions of IL-1β and MIP-2 mRNA were reduced in the lung of <em>Tlr2<sup>−/−</sup></em> mice <em>in vivo</em>. *<em>p&lt;0.005</em>, compared with CON in WT mice, **<em>p&lt;0.05</em> compared with NTHi inoculation in WT mice. Values are means ± S.D. (n = 3). D, NTHi-induced expressions of IL-1β and MIP-2 were reduced in the lung of <em>MyD88<sup>+/−</sup></em> mice <em>in vivo</em>. E, Histological analysis of lung of <em>Tlr2<sup>−/−</sup></em> mice revealed reduced inflammatory response by NTHi compared with WT mice (H&amp;E stain, ×200).</p>
<span>doi:10.1371/journal.pone.0001032.g003</span></div>

<h4>CYLD acts as a negative regulator for NTHi-induced NF-κB activation via negative cross-talk with TRAF6/7</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>Having demonstrated the critical role of TLR2-dependent MyD88-TRAF6/7 signaling pathway in NTHi-induced NF-κB-dependent inflammatory response, we next sought to determine if CYLD negatively regulates NTHi-induced NF-κB activation by targeting TRAF6/7. We initially evaluated the role of CYLD in activation of NF-κB and the resultant cytokine induction by NTHi by CYLD knockdown in human middle ear epithelial HMEEC-1 cells. We first confirmed the efficiency of CYLD-specific siRNA (siRNA-CYLD) in reducing CYLD expression. As expected, endogenous CYLD protein was markedly reduced by siRNA (<a href="#pone-0001032-g004"><strong>Fig. 4A</strong></a><strong>, upper panel</strong>). CYLD knockdown by using siRNA-CYLD enhanced activation of NF-κB by NTHi, whereas overexpression of WT-CYLD inhibited it (<a href="#pone-0001032-g004"><strong>Fig. 4A</strong></a><strong>, lower panel &amp; </strong><a href="#pone-0001032-g004"><strong>Fig. 4B</strong></a>). Moreover, CYLD knockdown enhanced NTHi-induced DNA binding activity of NF-κB (<a href="#pone-0001032-g004"><strong>Fig. 4C</strong></a>). Consistent with these results, siRNA-CYLD also enhanced the induction of IL-1β and IL-8 expression by NTHi in middle ear epithelial HMEEC-1 cells (<a href="#pone-0001032-g004"><strong>Fig. 4D</strong></a>). Similar results were also observed in human airway epithelial A549 cells and primary airway epithelial NHBE cells (Data not shown). Our data thus suggest that CYLD indeed acts as a negative regulator for NTHi-induced NF-κB-dependent inflammatory response in middle ear and respiratory epithelial cells.</p>
<div class="figure" id="pone-0001032-g004"><div class="img"><a name="pone-0001032-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>CYLD acts as a negative regulator for NTHi-induced NF-κB activation via negative cross-talk with TRAF6/7.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>A. CYLD knockdown by siRNA-CYLD markedly reduced expression of CYLD and enhanced NTHi-induced NF-κB-dependent promoter activity in HMEEC cells. B, overexpression of WT-CYLD inhibited NTHi-induced NF-κB-dependent promoter activity in HMEEC cells. C, NTHi-induced DNA binding activity of NF-κB was enhanced by CYLD knockdown, as assessed by EMSA. D, CYLD knockdown by siRNA-CYLD enhanced NTHi-induced IL-1β and IL-8 expression at mRNA level in HMEEC-1 cells. E, TRAF7 synergistically enhanced TRAF6-induced NF-κB-dependent promoter activity. Overexpression of WT-CYLD inhibited TRAF6- and TRAF7-induced NF-κB-dependent promoter activity, whereas CYLD knockdown by siRNA-CYLD enhanced TRAF6- and TRAF7-induced NF-κB-dependent promoter activity in lung epithelial A549 cells. *<em>p&lt;0.05</em>, compared with NTHi-inoculated in Mock in A, B and D. Values are means ± S.D. (n = 3).</p>
<span>doi:10.1371/journal.pone.0001032.g004</span></div><a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>We next sought to determine how CYLD inhibits NTHi-induced NF-κB activation. We previously showed that TRAF7 cooperates with TRAF6 in mediating NF-κB activation. Since we have shown that TRAF6 and 7 are involved in NTHi-induced NF-κB activation, it is likely that CYLD may inhibit NTHi-induced NF-κB activation by targeting TRAF6 and 7. We first tested our hypothesis by evaluating if CYLD knockdown or overexpressing WT CYLD alters NF-κB activation induced by expressing WT TRAF6 and 7. As shown in <a href="#pone-0001032-g004"><strong>Fig. 4E</strong></a>, TRAF7 synergistically enhanced TRAF6-induced NF-κB activation, and overexpression of WT-CYLD inhibited TRAF6 and 7-induced NF-κB activation, whereas CYLD knockdown by siRNA-CYLD enhanced NF-κB activation induced by wt-TRAF6 and 7. Our data thus suggests that CYLD inhibits NF-κB by targeting TRAF6 and 7.</p>


<h4>CYLD inhibits TRAF6 and TRAF7 in a deubiquitination-dependent manner</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>Because CYLD is known as a deubiquitinating enzyme (DUB) and polyubiquitination plays an important role in TRAFs activation <a href="#pone.0001032-Trompouki1">[16]</a>–<a href="#pone.0001032-Kovalenko1">[18]</a>, <a href="#pone.0001032-Yoshida1">[20]</a>, we next determined if CYLD deubiquitinates TRAF6 and 7. We first examined whether NTHi induces polyubiquitination of TRAF6 and TRAF7. As shown in the <a href="#pone-0001032-g005"><strong>Fig. 5A &amp; C</strong></a>, NTHi induced polyubiquitination of TRAF6 and TRAF7 in a time-dependent manner, respectively. Moreover, co-expression of WT-CYLD caused a reduction in TRAF6 and TRAF7 ubiquitination, and CYLD knockdown by siRNA-CYLD markedly increased levels of ubiquitinated TRAF6 and TRAF7 in HeLa cells (<a href="#pone-0001032-g005"><strong>Fig. 5B &amp; D</strong></a>). Together, we conclude that CYLD inhibits NTHi-induced NF-κB-dependent inflammatory response by deubiquitinating TRAF6 and TRAF7.</p>
<div class="figure" id="pone-0001032-g005"><div class="img"><a name="pone-0001032-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>CYLD inhibits TRAF6 and TRAF7 in a deubiquitination-dependent manner.</span></strong></p><a id="article1.body1.sec3.sec5.fig1.caption1.p1" name="article1.body1.sec3.sec5.fig1.caption1.p1"></a><p>A, NTHi induced ubiquitination of TRAF6. B, co-expressing WT-CYLD inhibited, whereas CYLD knockdown by siRNA-CYLD enhanced the ubiquitination of TRAF6 in HeLa cells. C, NTHi induced ubiquitination of TRAF7. D, co-expressing WT-CYLD inhibited, whereas CYLD knockdown by siRNA-CYLD enhanced the ubiquitination of TRAF7 in HeLa cells.</p>
<span>doi:10.1371/journal.pone.0001032.g005</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Negative feedback regulation plays a critical role in preventing overactive and detrimental inflammatory response in a variety of human diseases including infectious diseases <a href="#pone.0001032-Liew1">[31]</a>. To fully understand the molecular mechanisms underlying the negative regulation of inflammatory response in NTHi infections including otitis media and chronic obstructive pulmonary diseases, it is essential to identify the key receptor-mediated signaling adaptors. We previously showed that TLR2 is required for NTHi-induced NF-κB-dependent inflammatory response <a href="#pone.0001032-Watanabe1">[6]</a>, <a href="#pone.0001032-Shuto1">[9]</a>, <a href="#pone.0001032-Imasato1">[10]</a>. However, the key signaling adaptors that link TLR2 with NF-κB still remain unknown. In the present study, by overexpressing dominant-negative mutants of TLR2, MyD88 and TRAF6/7 and by using <em>Tlr2<sup>−/−</sup></em> and <em>MyD88<sup>+/−</sup></em> mice, we demonstrated that NTHi induced NF-κB-dependent inflammatory response through TLR2-dependent MyD88-TRAF6/7 signaling pathway (<a href="#pone-0001032-g006"><strong>Fig. 6</strong></a>). This finding is of particular interest because disrupting the signaling-mediated by TRAFs, the bottleneck of the receptor-mediated signaling, should efficiently block NTHi-induced TLR2-dependent NF-κB activation and the subsequent inflammatory response. Thus, the TRAF6/7 complex appears to be an attractive target for therapeutic intervention <a href="#pone.0001032-Deng1">[32]</a>–<a href="#pone.0001032-Habelhah1">[36]</a>. Indeed, over the past decade significant effort has been put into developing therapeutic strategies to shut down TRAF6 signaling for reducing the mortality associated with septic shock <a href="#pone.0001032-Fukushima1">[37]</a>. Since TRAF6/7 complex is essential for transducing NTHi-initiated signal from surface TLR to the NF-κB in the nucleus, it would be thus an ideal target for negative feedback regulation in the pathogenesis of bacteria infection.</p>
<div class="figure" id="pone-0001032-g006"><div class="img"><a name="pone-0001032-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001032" data-uri="info:doi/10.1371/journal.pone.0001032.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001032.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001032.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001032.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>Schematic representation of the negative regulation of NTHi-induced inflammatory response by CYLD.</span></strong></p><span>doi:10.1371/journal.pone.0001032.g006</span></div><a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>The deubiquitinating enzyme CYLD was initially identified as a tumor suppressor because loss of which causes a benign human tumor called cylindromatosis <a href="#pone.0001032-Bignell1">[13]</a>–<a href="#pone.0001032-PobleteGutierrez1">[15]</a>. <em>In vitro</em> studies indicate that CYLD inhibits TNF-α-induced NF-κB activation by deubiquitinating TRAF2 <a href="#pone.0001032-Trompouki1">[16]</a>–<a href="#pone.0001032-Kovalenko1">[18]</a>. Ubiquitination is previously known for its role in targeting proteins for degradation by the proteasome, but evidence of the nonproteolytic functions of ubiquitin is also rapidly accumulating. Initial evidence for the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the TRAF proteins, which function as ubiquitin ligases to synthesize lysine 63 (K63)-linked polyubiquitin chains to mediate activation of downstream kinases through a proteasome-independent mechanism <a href="#pone.0001032-Chen1">[38]</a>. Despite the role of CYLD in inhibiting TRAF2 by deubiquitinating it, its role in deubiquitinating other TRAF family members remains unclear. The role of CYLD in regulating NTHi-induced NF-κB activation also remains unknown. Moreover, despite its known role in regulating T-cell development and tumor cell proliferation <em>in vivo</em> <a href="#pone.0001032-Reiley3">[39]</a>, <a href="#pone.0001032-Massoumi1">[40]</a>, its role in regulating inflammation in bacterial infections <em>in vivo</em> is still unclear. In the present study, we have shown that, by performing the inflammatory phenotype analysis of <em>Cyld<sup>−/−</sup></em> mice, CYLD negatively regulates NTHi-induced inflammatory response in the middle ear and lung of <em>Cyld<sup>−/−</sup></em> mice (<a href="#pone-0001032-g001"><strong>Fig. 1</strong></a>), and this negative regulation results in enhanced pathological changes in the middle ear and lung as well as increased expression of pro-inflammatory mediators <em>in vivo</em>. Thus our data provide direct <em>in vivo</em> evidence for the negative regulation of CYLD in NTHi-induced inflammation via a deubiquitination-dependent inhibition of TRAF6/7 in the middle ear and lungs of mice.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>In the present study, it is clear that CYLD acts as a critical negative regulator for NTHi-induced inflammation in the middle ear and lung. However, the expression of CYLD in the middle ear and lung is relatively low under physiological condition. Moreover, <em>Cyld<sup>−/−</sup></em> mice exhibit no overt abnormalities under normal conditions <a href="#pone.0001032-Zhang1">[21]</a>, <a href="#pone.0001032-Massoumi1">[40]</a>. Moreover it was recently reported that <em>Cyld<sup>−/−</sup></em> mice are more susceptible to chemical-induced skin-tumorigenesis even though they appear normal under physiological condition. These interesting findings thus led us to hypothesize that CYLD, although expressed at relatively low level under physiological conditions, is up-regulated by bacteria during middle ear and lung infection, which in turn leads to the attenuation of NTHi-induced inflammation. In view of CYLD in negative regulation of bacteria-induced TLR2-dependent inflammatory response, it is interesting to note that CYLD expression itself is also regulated by bacteria-induced TLR activation <a href="#pone.0001032-Yoshida1">[20]</a>, <a href="#pone.0001032-Jono1">[23]</a>. CYLD is induced rapidly after activation of TLR2 by various bacterial pathogens including PGN, MALP-2, Pam3CSK4, and NTHi. Our finding reveals novel molecular mechanisms by which bacterial pathogens including NTHi induce CYLD expression, which in turn attenuates bacteria-induced inflammatory response. Given that prolonged CYLD expression is anticipated to suppress adequate host response to the invading pathogens, which is necessary for the adequate host defense, it is also of particular interest to investigate how CYLD expression is negatively regulated. This study should provide novel insights into how inflammation is tightly regulated and may lead to the development of novel therapeutic strategies for modulating inflammation.</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We are grateful to Drs. R. Bernards and G. Courtois for kindly providing reagents.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: J-DL JHL. Performed the experiments: JHL HJ TK HI UH HX CW PB HX. Analyzed the data: JHL HJ TK HI UH HX CW PB HX. Contributed reagents/materials/analysis tools: J-DL. Wrote the paper: J-DL JHL.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001032-Foxwell1" id="pone.0001032-Foxwell1"></a>Foxwell AR, Kyd JM, Cripps AW (1998) Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev  62: 294–308.  <ul class="find" data-citedArticleID="1005038"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Nontypeable+Haemophilus+influenzae%3A+pathogenesis+and+prevention.&amp;auth=&amp;atitle=Nontypeable+Haemophilus+influenzae%3A+pathogenesis+and+prevention." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nontypeable+Haemophilus+influenzae%3A+pathogenesis+and+prevention." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nontypeable+Haemophilus+influenzae%3A+pathogenesis+and+prevention.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001032-Rao1" id="pone.0001032-Rao1"></a>Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW 3rd (1999) Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev  23: 99–129.  <ul class="find" data-citedArticleID="1005074" data-doi="10.1111/j.1574-6976.1999.tb00393.x"><li><a href="http://dx.doi.org/10.1111/j.1574-6976.1999.tb00393.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+determinants+of+the+pathogenesis+of+disease+due+to+non-typable+Haemophilus+influenzae." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+determinants+of+the+pathogenesis+of+disease+due+to+non-typable+Haemophilus+influenzae.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001032-Sethi1" id="pone.0001032-Sethi1"></a>Sethi S, Murphy TF (2000) Chronic obstructive pulmonary disease. N Engl J Med  343: 1969–1970.  <ul class="find" data-citedArticleID="1005084" data-doi="10.1056/nejm200012283432615"><li><a href="http://dx.doi.org/10.1056/nejm200012283432615" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chronic+obstructive+pulmonary+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chronic+obstructive+pulmonary+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001032-Murphy1" id="pone.0001032-Murphy1"></a>Murphy TF (2000) Haemophilus influenzae in chronic bronchitis. Semin Respir Infect  15: 41–51.  <ul class="find" data-citedArticleID="1005068"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Haemophilus+influenzae+in+chronic+bronchitis.&amp;auth=&amp;atitle=Haemophilus+influenzae+in+chronic+bronchitis." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Haemophilus+influenzae+in+chronic+bronchitis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Haemophilus+influenzae+in+chronic+bronchitis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001032-Murphy2" id="pone.0001032-Murphy2"></a>Murphy TF (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis  19: 225–230.  <ul class="find" data-citedArticleID="1005070" data-doi="10.1097/01.qco.0000224815.89363.15"><li><a href="http://dx.doi.org/10.1097/01.qco.0000224815.89363.15" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+role+of+bacteria+in+airway+inflammation+in+exacerbations+of+chronic+obstructive+pulmonary+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+role+of+bacteria+in+airway+inflammation+in+exacerbations+of+chronic+obstructive+pulmonary+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001032-Watanabe1" id="pone.0001032-Watanabe1"></a>Watanabe T, Jono H, Han J, Lim DJ, Li JD (2004) Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc Natl Acad Sci USA  101: 3563–3568.  <ul class="find" data-citedArticleID="1005094" data-doi="10.1073/pnas.0400557101"><li><a href="http://dx.doi.org/10.1073/pnas.0400557101" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synergistic+activation+of+NF-kappaB+by+nontypeable+Haemophilus+influenzae+and+tumor+necrosis+factor+alpha." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synergistic+activation+of+NF-kappaB+by+nontypeable+Haemophilus+influenzae+and+tumor+necrosis+factor+alpha.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001032-Hayden1" id="pone.0001032-Hayden1"></a>Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev  18: 2195–2224.  <ul class="find" data-citedArticleID="1005046" data-doi="10.1101/gad.1228704"><li><a href="http://dx.doi.org/10.1101/gad.1228704" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Signaling+to+NF-kappaB." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Signaling+to+NF-kappaB.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001032-Ghosh1" id="pone.0001032-Ghosh1"></a>Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell  109:: SupplS81–96.  <ul class="find" data-citedArticleID="1005042" data-doi="10.1016/s0092-8674(02)00703-1"><li><a href="http://dx.doi.org/10.1016/s0092-8674(02)00703-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Missing+pieces+in+the+NF-kappaB+puzzle." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Missing+pieces+in+the+NF-kappaB+puzzle.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001032-Shuto1" id="pone.0001032-Shuto1"></a>Shuto T, Xu H, Wang B, Han J, Kai H, et al.  (2001) Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA  98: 8774–8779.  <ul class="find" data-citedArticleID="1005086" data-doi="10.1073/pnas.151236098"><li><a href="http://dx.doi.org/10.1073/pnas.151236098" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activation+of+NF-kappa+B+by+nontypeable+Hemophilus+influenzae+is+mediated+by+toll-like+receptor+2-TAK1-dependent+NIK-IKK+alpha%2Fbeta-I+kappa+B+alpha+and+MKK3%2F6-p38+MAP+kinase+signaling+pathways+in+epithelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activation+of+NF-kappa+B+by+nontypeable+Hemophilus+influenzae+is+mediated+by+toll-like+receptor+2-TAK1-dependent+NIK-IKK+alpha%2Fbeta-I+kappa+B+alpha+and+MKK3%2F6-p38+MAP+kinase+signaling+pathways+in+epithelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001032-Imasato1" id="pone.0001032-Imasato1"></a>Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, et al.  (2002) Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem  277: 47444–47450.  <ul class="find" data-citedArticleID="1005048" data-doi="10.1074/jbc.m208140200"><li><a href="http://dx.doi.org/10.1074/jbc.m208140200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+p38+MAPK+by+glucocorticoids+via+induction+of+MAPK+phosphatase-1+enhances+nontypeable+Haemophilus+influenzae-induced+expression+of+toll-like+receptor+2." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+p38+MAPK+by+glucocorticoids+via+induction+of+MAPK+phosphatase-1+enhances+nontypeable+Haemophilus+influenzae-induced+expression+of+toll-like+receptor+2.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001032-Ulevitch1" id="pone.0001032-Ulevitch1"></a>Ulevitch RJ, Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol  13: 437–457.  <ul class="find" data-citedArticleID="1005092" data-doi="10.1146/annurev.iy.13.040195.002253"><li><a href="http://dx.doi.org/10.1146/annurev.iy.13.040195.002253" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Receptor-dependent+mechanisms+of+cell+stimulation+by+bacterial+endotoxin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Receptor-dependent+mechanisms+of+cell+stimulation+by+bacterial+endotoxin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001032-KurtJones1" id="pone.0001032-KurtJones1"></a>Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, et al.  (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA  101: 1315–1320.  <ul class="find" data-citedArticleID="1005058" data-doi="10.1073/pnas.0308057100"><li><a href="http://dx.doi.org/10.1073/pnas.0308057100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Herpes+simplex+virus+1+interaction+with+Toll-like+receptor+2+contributes+to+lethal+encephalitis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Herpes+simplex+virus+1+interaction+with+Toll-like+receptor+2+contributes+to+lethal+encephalitis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001032-Bignell1" id="pone.0001032-Bignell1"></a>Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, et al.  (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet  25: 160–165.  <ul class="find" data-citedArticleID="1005028"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Identification+of+the+familial+cylindromatosis+tumour-suppressor+gene.&amp;auth=&amp;atitle=Identification+of+the+familial+cylindromatosis+tumour-suppressor+gene." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+the+familial+cylindromatosis+tumour-suppressor+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+the+familial+cylindromatosis+tumour-suppressor+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001032-Leonard1" id="pone.0001032-Leonard1"></a>Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, et al.  (2001) Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol  54: 689–692.  <ul class="find" data-citedArticleID="1005062" data-doi="10.1136/jcp.54.9.689"><li><a href="http://dx.doi.org/10.1136/jcp.54.9.689" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Loss+of+heterozygosity+at+cylindromatosis+gene+locus%2C+CYLD%2C+in+sporadic+skin+adnexal+tumours." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Loss+of+heterozygosity+at+cylindromatosis+gene+locus%2C+CYLD%2C+in+sporadic+skin+adnexal+tumours.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001032-PobleteGutierrez1" id="pone.0001032-PobleteGutierrez1"></a>Poblete Gutierrez P, Eggermann T, Holler D, Jugert FK, Beermann T, et al.  (2002) Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol  119: 527–531.  <ul class="find" data-citedArticleID="1005072" data-doi="10.1046/j.1523-1747.2002.01839.x"><li><a href="http://dx.doi.org/10.1046/j.1523-1747.2002.01839.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phenotype+diversity+in+familial+cylindromatosis%3A+a+frameshift+mutation+in+the+tumor+suppressor+gene+CYLD+underlies+different+tumors+of+skin+appendages." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phenotype+diversity+in+familial+cylindromatosis%3A+a+frameshift+mutation+in+the+tumor+suppressor+gene+CYLD+underlies+different+tumors+of+skin+appendages.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001032-Trompouki1" id="pone.0001032-Trompouki1"></a>Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, et al.  (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature  424: 793–796.  <ul class="find" data-citedArticleID="1005090" data-doi="10.1038/nature01803"><li><a href="http://dx.doi.org/10.1038/nature01803" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CYLD+is+a+deubiquitinating+enzyme+that+negatively+regulates+NF-kappaB+activation+by+TNFR+family+members." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CYLD+is+a+deubiquitinating+enzyme+that+negatively+regulates+NF-kappaB+activation+by+TNFR+family+members.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001032-Brummelkamp1" id="pone.0001032-Brummelkamp1"></a>Brummelkamp TR, Nijman SM, Dirac AM, Bernards R (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature  424: 797–801.  <ul class="find" data-citedArticleID="1005030" data-doi="10.1038/nature01811"><li><a href="http://dx.doi.org/10.1038/nature01811" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Loss+of+the+cylindromatosis+tumour+suppressor+inhibits+apoptosis+by+activating+NF-kappaB." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Loss+of+the+cylindromatosis+tumour+suppressor+inhibits+apoptosis+by+activating+NF-kappaB.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001032-Kovalenko1" id="pone.0001032-Kovalenko1"></a>Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, et al.  (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature  424: 801–805.  <ul class="find" data-citedArticleID="1005056" data-doi="10.1038/nature01802"><li><a href="http://dx.doi.org/10.1038/nature01802" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+tumour+suppressor+CYLD+negatively+regulates+NF-kappaB+signalling+by+deubiquitination." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+tumour+suppressor+CYLD+negatively+regulates+NF-kappaB+signalling+by+deubiquitination.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001032-Reiley1" id="pone.0001032-Reiley1"></a>Reiley W, Zhang M, Sun SC (2004) Negative regulation of JNK signaling by the tumor suppressor CYLD. J Biol Chem  279: 55161–55167.  <ul class="find" data-citedArticleID="1005076" data-doi="10.1074/jbc.m411049200"><li><a href="http://dx.doi.org/10.1074/jbc.m411049200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Negative+regulation+of+JNK+signaling+by+the+tumor+suppressor+CYLD." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Negative+regulation+of+JNK+signaling+by+the+tumor+suppressor+CYLD.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001032-Yoshida1" id="pone.0001032-Yoshida1"></a>Yoshida H, Jono H, Kai H, Li JD (2005) The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem  280: 41111–41121.  <ul class="find" data-citedArticleID="1005098" data-doi="10.1074/jbc.m509526200"><li><a href="http://dx.doi.org/10.1074/jbc.m509526200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+tumor+suppressor+cylindromatosis+%28CYLD%29+acts+as+a+negative+regulator+for+toll-like+receptor+2+signaling+via+negative+cross-talk+with+TRAF6+AND+TRAF7." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+tumor+suppressor+cylindromatosis+%28CYLD%29+acts+as+a+negative+regulator+for+toll-like+receptor+2+signaling+via+negative+cross-talk+with+TRAF6+AND+TRAF7.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001032-Zhang1" id="pone.0001032-Zhang1"></a>Zhang J, Stirling B, Temmerman ST, Ma CA, Fuss IJ, et al.  (2006) Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest  116: 3042–3049.  <ul class="find" data-citedArticleID="1005100" data-doi="10.1172/jci28746"><li><a href="http://dx.doi.org/10.1172/jci28746" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Impaired+regulation+of+NF-kappaB+and+increased+susceptibility+to+colitis-associated+tumorigenesis+in+CYLD-deficient+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Impaired+regulation+of+NF-kappaB+and+increased+susceptibility+to+colitis-associated+tumorigenesis+in+CYLD-deficient+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001032-Reiley2" id="pone.0001032-Reiley2"></a>Reiley WW, Jin W, Lee AJ, Wright A, Wu X, et al.  (2007) Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med  204: 1475–1485.  <ul class="find" data-citedArticleID="1005078" data-doi="10.1084/jem.20062694"><li><a href="http://dx.doi.org/10.1084/jem.20062694" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Deubiquitinating+enzyme+CYLD+negatively+regulates+the+ubiquitin-dependent+kinase+Tak1+and+prevents+abnormal+T+cell+responses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Deubiquitinating+enzyme+CYLD+negatively+regulates+the+ubiquitin-dependent+kinase+Tak1+and+prevents+abnormal+T+cell+responses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001032-Jono1" id="pone.0001032-Jono1"></a>Jono H, Lim JH, Chen LF, Xu H, Trompouki E, et al.  (2004) NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem  279: 36171–36174.  <ul class="find" data-citedArticleID="1005052" data-doi="10.1074/jbc.m406638200"><li><a href="http://dx.doi.org/10.1074/jbc.m406638200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=NF-kappaB+is+essential+for+induction+of+CYLD%2C+the+negative+regulator+of+NF-kappaB%3A+evidence+for+a+novel+inducible+autoregulatory+feedback+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22NF-kappaB+is+essential+for+induction+of+CYLD%2C+the+negative+regulator+of+NF-kappaB%3A+evidence+for+a+novel+inducible+autoregulatory+feedback+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001032-Takeuchi1" id="pone.0001032-Takeuchi1"></a>Takeuchi O, Hoshino K, Akira S (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol  165: 5392–5396.  <ul class="find" data-citedArticleID="1005088"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Cutting+edge%3A+TLR2-deficient+and+MyD88-deficient+mice+are+highly+susceptible+to+Staphylococcus+aureus+infection.&amp;auth=&amp;atitle=Cutting+edge%3A+TLR2-deficient+and+MyD88-deficient+mice+are+highly+susceptible+to+Staphylococcus+aureus+infection." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cutting+edge%3A+TLR2-deficient+and+MyD88-deficient+mice+are+highly+susceptible+to+Staphylococcus+aureus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cutting+edge%3A+TLR2-deficient+and+MyD88-deficient+mice+are+highly+susceptible+to+Staphylococcus+aureus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001032-Kweon1" id="pone.0001032-Kweon1"></a>Kweon SM, Wang B, Rixter D, Lim JH, Koga T, et al.  (2006) Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK. Biochem Biophys Res Commun  351: 368–375.  <ul class="find" data-citedArticleID="1005060" data-doi="10.1016/j.bbrc.2006.10.052"><li><a href="http://dx.doi.org/10.1016/j.bbrc.2006.10.052" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synergistic+activation+of+NF-kappaB+by+nontypeable+H.+influenzae+and+S.+pneumoniae+is+mediated+by+CK2%2C+IKKbeta-IkappaBalpha%2C+and+p38+MAPK." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synergistic+activation+of+NF-kappaB+by+nontypeable+H.+influenzae+and+S.+pneumoniae+is+mediated+by+CK2%2C+IKKbeta-IkappaBalpha%2C+and+p38+MAPK.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001032-Sakai1" id="pone.0001032-Sakai1"></a>Sakai A, Han J, Cato AC, Akira S, Li JD (2004) Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol,  5: 2.  <ul class="find" data-citedArticleID="1005082"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Glucocorticoids+synergize+with+IL-1beta+to+induce+TLR2+expression+via+MAP+Kinase+Phosphatase-1-dependent+dual+Inhibition+of+MAPK+JNK+and+p38+in+epithelial+cells.&amp;auth=&amp;atitle=Glucocorticoids+synergize+with+IL-1beta+to+induce+TLR2+expression+via+MAP+Kinase+Phosphatase-1-dependent+dual+Inhibition+of+MAPK+JNK+and+p38+in+epithelial+cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Glucocorticoids+synergize+with+IL-1beta+to+induce+TLR2+expression+via+MAP+Kinase+Phosphatase-1-dependent+dual+Inhibition+of+MAPK+JNK+and+p38+in+epithelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Glucocorticoids+synergize+with+IL-1beta+to+induce+TLR2+expression+via+MAP+Kinase+Phosphatase-1-dependent+dual+Inhibition+of+MAPK+JNK+and+p38+in+epithelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001032-Kim1" id="pone.0001032-Kim1"></a>Kim S, Schein AJ, Nadel JA (2005) E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol  289: L1049–1060.  <ul class="find" data-citedArticleID="1005054" data-doi="10.1152/ajplung.00388.2004"><li><a href="http://dx.doi.org/10.1152/ajplung.00388.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=E-cadherin+promotes+EGFR-mediated+cell+differentiation+and+MUC5AC+mucin+expression+in+cultured+human+airway+epithelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22E-cadherin+promotes+EGFR-mediated+cell+differentiation+and+MUC5AC+mucin+expression+in+cultured+human+airway+epithelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001032-Dunne1" id="pone.0001032-Dunne1"></a>Dunne A, O'Neill LA (2003) The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE  2003: re3.  <ul class="find" data-citedArticleID="1005036" data-doi="10.1126/stke.2003.171.re3"><li><a href="http://dx.doi.org/10.1126/stke.2003.171.re3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+interleukin-1+receptor%2FToll-like+receptor+superfamily%3A+signal+transduction+during+inflammation+and+host+defense." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+interleukin-1+receptor%2FToll-like+receptor+superfamily%3A+signal+transduction+during+inflammation+and+host+defense.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001032-Akira1" id="pone.0001032-Akira1"></a>Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol  4: 499–511.  <ul class="find" data-citedArticleID="1005022" data-doi="10.1038/nri1391"><li><a href="http://dx.doi.org/10.1038/nri1391" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Toll-like+receptor+signalling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Toll-like+receptor+signalling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001032-Beutler1" id="pone.0001032-Beutler1"></a>Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature  430: 257–263.  <ul class="find" data-citedArticleID="1005026" data-doi="10.1038/nature02761"><li><a href="http://dx.doi.org/10.1038/nature02761" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inferences%2C+questions+and+possibilities+in+Toll-like+receptor+signalling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inferences%2C+questions+and+possibilities+in+Toll-like+receptor+signalling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001032-Liew1" id="pone.0001032-Liew1"></a>Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol  5: 446–458.  <ul class="find" data-citedArticleID="1005064" data-doi="10.1038/nri1630"><li><a href="http://dx.doi.org/10.1038/nri1630" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Negative+regulation+of+toll-like+receptor-mediated+immune+responses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Negative+regulation+of+toll-like+receptor-mediated+immune+responses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001032-Deng1" id="pone.0001032-Deng1"></a>Deng L, Wang C, Spencer E, Yang L, Braun A, You J, et al.  (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell  103: 351–361.  <ul class="find" data-citedArticleID="1005034" data-doi="10.1016/s0092-8674(00)00126-4"><li><a href="http://dx.doi.org/10.1016/s0092-8674(00)00126-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activation+of+the+IkappaB+kinase+complex+by+TRAF6+requires+a+dimeric+ubiquitin-conjugating+enzyme+complex+and+a+unique+polyubiquitin+chain." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activation+of+the+IkappaB+kinase+complex+by+TRAF6+requires+a+dimeric+ubiquitin-conjugating+enzyme+complex+and+a+unique+polyubiquitin+chain.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001032-Inoue1" id="pone.0001032-Inoue1"></a>Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, et al.  (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res  254: 14–24.  <ul class="find" data-citedArticleID="1005050" data-doi="10.1006/excr.1999.4733"><li><a href="http://dx.doi.org/10.1006/excr.1999.4733" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tumor+necrosis+factor+receptor-associated+factor+%28TRAF%29+family%3A+adapter+proteins+that+mediate+cytokine+signaling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tumor+necrosis+factor+receptor-associated+factor+%28TRAF%29+family%3A+adapter+proteins+that+mediate+cytokine+signaling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001032-Weissman1" id="pone.0001032-Weissman1"></a>Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol  2: 169–178.  <ul class="find" data-citedArticleID="1005096" data-doi="10.1038/35056563"><li><a href="http://dx.doi.org/10.1038/35056563" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Themes+and+variations+on+ubiquitylation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Themes+and+variations+on+ubiquitylation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001032-BenNeriah1" id="pone.0001032-BenNeriah1"></a>Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol  3: 20–26.  <ul class="find" data-citedArticleID="1005024" data-doi="10.1038/ni0102-20"><li><a href="http://dx.doi.org/10.1038/ni0102-20" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulatory+functions+of+ubiquitination+in+the+immune+system." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulatory+functions+of+ubiquitination+in+the+immune+system.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001032-Habelhah1" id="pone.0001032-Habelhah1"></a>Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, et al.  (2004) Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J  23: 322–332.  <ul class="find" data-citedArticleID="1005044" data-doi="10.1038/sj.emboj.7600044"><li><a href="http://dx.doi.org/10.1038/sj.emboj.7600044" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ubiquitination+and+translocation+of+TRAF2+is+required+for+activation+of+JNK+but+not+of+p38+or+NF-kappaB." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ubiquitination+and+translocation+of+TRAF2+is+required+for+activation+of+JNK+but+not+of+p38+or+NF-kappaB.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001032-Fukushima1" id="pone.0001032-Fukushima1"></a>Fukushima T, Matsuzawa S, Kress CL, Bruey JM, Krajewska M, et al.  (2007) Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc Natl Acad Sci USA  104: 6371–6376.  <ul class="find" data-citedArticleID="1005040" data-doi="10.1073/pnas.0700548104"><li><a href="http://dx.doi.org/10.1073/pnas.0700548104" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ubiquitin-conjugating+enzyme+Ubc13+is+a+critical+component+of+TNF+receptor-associated+factor+%28TRAF%29-mediated+inflammatory+responses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ubiquitin-conjugating+enzyme+Ubc13+is+a+critical+component+of+TNF+receptor-associated+factor+%28TRAF%29-mediated+inflammatory+responses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001032-Chen1" id="pone.0001032-Chen1"></a>Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol  7: 758–765.  <ul class="find" data-citedArticleID="1005032" data-doi="10.1038/ncb0805-758"><li><a href="http://dx.doi.org/10.1038/ncb0805-758" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ubiquitin+signalling+in+the+NF-kappaB+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ubiquitin+signalling+in+the+NF-kappaB+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001032-Reiley3" id="pone.0001032-Reiley3"></a>Reiley WW, Zhang M, Jin W, Losiewicz M, Donohue KB, et al.  (2006) Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol  7: 411–417.  <ul class="find" data-citedArticleID="1005080" data-doi="10.1038/ni1315"><li><a href="http://dx.doi.org/10.1038/ni1315" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+T+cell+development+by+the+deubiquitinating+enzyme+CYLD." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+T+cell+development+by+the+deubiquitinating+enzyme+CYLD.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001032-Massoumi1" id="pone.0001032-Massoumi1"></a>Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell  125: 665–677.  <ul class="find" data-citedArticleID="1005066" data-doi="10.1016/j.cell.2006.03.041"><li><a href="http://dx.doi.org/10.1016/j.cell.2006.03.041" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cyld+inhibits+tumor+cell+proliferation+by+blocking+Bcl-3-dependent+NF-kappaB+signaling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cyld+inhibits+tumor+cell+proliferation+by+blocking+Bcl-3-dependent+NF-kappaB+signaling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.XML" value="82469"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.PDF" value="3924819"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g001.PNG_L" value="1547367"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g001.PNG_M" value="385360"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g001.PNG_S" value="19466"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g001.TIF" value="2186896"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g001.PNG_I" value="120182"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g002.PNG_L" value="317748"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g002.PNG_M" value="60118"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g002.PNG_S" value="9561"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g002.TIF" value="392860"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g002.PNG_I" value="20773"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g003.PNG_L" value="858051"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g003.PNG_M" value="243687"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g003.PNG_S" value="18068"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g003.TIF" value="1233000"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g003.PNG_I" value="80576"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g004.PNG_L" value="248470"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g004.PNG_M" value="52499"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g004.PNG_S" value="9271"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g004.TIF" value="367518"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g004.PNG_I" value="18479"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g005.PNG_L" value="641918"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g005.PNG_M" value="97025"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g005.PNG_S" value="11311"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g005.TIF" value="640564"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g005.PNG_I" value="32025"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g006.PNG_L" value="303696"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g006.PNG_M" value="88546"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g006.PNG_S" value="13174"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g006.TIF" value="536318"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001032.g006.PNG_I" value="41596"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001032&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001032" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001032&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001032&volume=&issue=&title=Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice&author_name=Jae%20Hyang%20Lim%2C%20Hirofumi%20Jono%2C%20Tomoaki%20Koga%2C%20Chang-Hoon%20Woo%2C%20Hajime%20Ishinaga%2C%20Patricia%20Bourne%2C%20Haodong%20Xu%2C%20Un-Hwan%20Ha%2C%20Haidong%20Xu%2C%20Jian-Dong%20Li&start_page=1&end_page=10" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001032" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032&amp;t=Tumor%20Suppressor%20CYLD%20Acts%20as%20a%20Negative%20Regulator%20for%20Non-Typeable%20Haemophilus%20influenza-Induced%20Inflammation%20in%20the%20Middle%20Ear%20and%20Lung%20of%20Mice" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032&title=Tumor%20Suppressor%20CYLD%20Acts%20as%20a%20Negative%20Regulator%20for%20Non-Typeable%20Haemophilus%20influenza-Induced%20Inflammation%20in%20the%20Middle%20Ear%20and%20Lung%20of%20Mice&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032&amp;title=Tumor%20Suppressor%20CYLD%20Acts%20as%20a%20Negative%20Regulator%20for%20Non-Typeable%20Haemophilus%20influenza-Induced%20Inflammation%20in%20the%20Middle%20Ear%20and%20Lung%20of%20Mice" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001032&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001032';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Tumor%20Suppressor%20CYLD%20Acts%20as%20a%20Negative%20Regulator%20for%20Non-Typeable%20Haemophilus%20influenza-Induced%20Inflammation%20in%20the%20Middle%20Ear%20and%20Lung%20of%20Mice http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001032" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001032" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">













          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Bacterial+diseases%22" title="Search for articles in the subject area:'Bacterial diseases'"><div class="flagText">Bacterial diseases</div></a>
              <div data-categoryid="47923" data-articleid="24898"
                   data-categoryname="Bacterial diseases"
                   class="flagImage" title="Flag 'Bacterial diseases' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Bacterial+pathogens%22" title="Search for articles in the subject area:'Bacterial pathogens'"><div class="flagText">Bacterial pathogens</div></a>
              <div data-categoryid="42719" data-articleid="24898"
                   data-categoryname="Bacterial pathogens"
                   class="flagImage" title="Flag 'Bacterial pathogens' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Histology%22" title="Search for articles in the subject area:'Histology'"><div class="flagText">Histology</div></a>
              <div data-categoryid="47559" data-articleid="24898"
                   data-categoryname="Histology"
                   class="flagImage" title="Flag 'Histology' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Immune+receptor+signaling%22" title="Search for articles in the subject area:'Immune receptor signaling'"><div class="flagText">Immune receptor signaling</div></a>
              <div data-categoryid="19743" data-articleid="24898"
                   data-categoryname="Immune receptor signaling"
                   class="flagImage" title="Flag 'Immune receptor signaling' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Inflammation%22" title="Search for articles in the subject area:'Inflammation'"><div class="flagText">Inflammation</div></a>
              <div data-categoryid="32301" data-articleid="24898"
                   data-categoryname="Inflammation"
                   class="flagImage" title="Flag 'Inflammation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Inflammatory+diseases%22" title="Search for articles in the subject area:'Inflammatory diseases'"><div class="flagText">Inflammatory diseases</div></a>
              <div data-categoryid="2615" data-articleid="24898"
                   data-categoryname="Inflammatory diseases"
                   class="flagImage" title="Flag 'Inflammatory diseases' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Middle+ear%22" title="Search for articles in the subject area:'Middle ear'"><div class="flagText">Middle ear</div></a>
              <div data-categoryid="48423" data-articleid="24898"
                   data-categoryname="Middle ear"
                   class="flagImage" title="Flag 'Middle ear' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Otitis+media%22" title="Search for articles in the subject area:'Otitis media'"><div class="flagText">Otitis media</div></a>
              <div data-categoryid="24797" data-articleid="24898"
                   data-categoryname="Otitis media"
                   class="flagImage" title="Flag 'Otitis media' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=5294'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=4549'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=1834&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
